Under what circumstances you would consider treating stage II colon cancer with adjuvant chemotherapy?
When would you consider use of ctDNA to help with this decision?
Answer from: Medical Oncologist at Academic Institution
This is a very interesting question especially at present time. We know not every patient with stage II colon cancer will benefit from adjuvant chemotherapy, and the absolute survival benefit is less than 5% for 5FU based adjuvant chemo treatment (but no category 1 evidence). Oxaliplatin-...
Comments
Medical Oncologist at Alvin & Lois Lapidus Cancer Institute Northwest Hospital In an MMR deficient patient with high-risk feature...
Medical Oncologist at Mayo Clinic This population was not well studied and I will be...
Medical Oncologist at Los Angeles VA Medical Center We have two other Q&A threads that discuss MMR...
In an MMR deficient patient with high-risk feature...
This population was not well studied and I will be...
We have two other Q&A threads that discuss MMR...